Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001731122-24-000254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-15 | 2024-02-13 | LNAI | Sindlev Rene | Dir, 10% | C - Cnv Deriv | — | +701.3K | 13.13M | +6% | — |
| DI | 2024-02-15 | 2024-02-13 | LNAI | Sindlev Rene | Dir, 10% | C - Cnv Deriv | $0.00 | -70.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | C | A | 701,260 | — | 13,133,598 | I By RS Bio ApS | — | — | (F1) Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share. |
| 2 | Derivative | Series A Convertible Preferred Stock | 2024-02-13 | C | D | 70,126 | $0.00 | 0 | I By RS Bio ApS | $0.00 · 2023-08-01 to — | 701,260 Common Stock | (F2) The Preferred Stock is convertible into Common Stock on a one-for-ten basis. (F3) The Preferred Stock is perpetual and has no expiration date. |